Phocal Phn
NDC Package 55918-002-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Phocal Phn is phocal disks are topical delivery vehicles designed to fluoridate interproximal tooth surfaces. Marketed by Phocal Therapy Inc, this product is identified by NDC 55918-002.

Identification & Billing

NDC Package Code
55918-002-20
Package Description
2 BLISTER PACK in 1 BOX / 10 DISC in 1 BLISTER PACK
Product Code
11-Digit Billing Format
55918000220

Clinical Specifications

Proprietary Name
Phocal Phn
Dosage Form
-
Usage Information
Phocal disks are topical delivery vehicles designed to fluoridate interproximal tooth surfaces. This action aids in the prevention of dental caries on intact surfaces, arrests progress on surfaces with incipient carious lesions and enhances remineralization. Phocal disks are also effective at tooth restoration margins and furcations. Phocal disks are to be applied only by dental professionals at selected sites to achieve the desired benefits.

Regulatory & Marketing

Labeler Name
Phocal Therapy Inc
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
01-01-2013
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55918-002-20 identifies a specific commercial package of 2 blister pack in 1 box / 10 disc in 1 blister pack of Phocal Phn, labeled by Phocal Therapy Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Phocal Therapy Inc on January 01, 2013. The current certification is valid through December 31, 2017.

How is this Phocal Therapy Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55918000220. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
55918-002-20
11-Digit CMS (5-4-2)
55918-0002-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.